🔎 Trials Near Me

Akèy › Atak kè › Pennsylvania › Philadelphia

Etid klinik pou Atak kè nan Philadelphia, PA

3 etid pou Atak kè ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Ap rekriteFaz 2/3
  • Clinical Renal Associates, LTD, Exton · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Ap rekriteFaz 3
  • Perelman School of Medicine, Philadelphia
Laj 18 a 100 · Tout sèks · Mizajou Sep 4, 2026 · NCT07517263

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

Ap rekriteFaz 3
  • University of Pennsylvania, Philadelphia
Laj 50 a 105 · Tout sèks · Mizajou Aug 21, 2026 · NCT07136012

Etid Atak kè nan lòt vil

Lòt etid nan Philadelphia

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.